Myasthenia gravis as a prototype autoimmune receptor disease

Autor: De Baets Mh, van Breda Vriesman Pj, Hoedemaekers Ac

Publikováno v: Immunologic Research. 16:341-354

Myasthenia gravis (MG) is an organ-specific autoimmune disease in which autoantibodies against nicotinic acetylcholine receptors (AChR) at the postsynaptic membrane cause loss of functional AChR and disturbed neuromuscular transmission. The immunopat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d5794b8e406ffbccb1b3f8e029ee97c
https://doi.org/10.1007/bf02786398

Coimmunization of MHC class II competitor peptides during experimental autoimmune myasthenia gravis induction resulted not only in a suppressed, but also in an altered immune response.

Autor: Wauben MH; Institute of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, The Netherlands., Hoedemaekers AC, Graus YM, Wagenaar JP, Van Eden W, De Baets MH

Publikováno v: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 1998 May 13; Vol. 841, pp. 338-41.

Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune response.

Autor: Wauben MH; Institute of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, The Netherlands. M.Wauben@vetmic.dgk.ruu.nl, Hoedemaekers AC, Graus YM, Wagenaar JP, van Eden W, de Baets MH

Publikováno v: European journal of immunology [Eur J Immunol] 1996 Dec; Vol. 26 (12), pp. 2866-75.